改善溃疡性结肠炎疾病严重程度的实时分类:人工智能作为第二意见的触发因素
该研究训练卷积神经网络基于645例患者的2561张图像和53段视频进行溃疡性结肠炎内镜严重程度分类,验证集为44例患者的140段视频。模型准确率达82%,与专家无显著差异;作为支持系统使非IBD专家表现提升12%,并在真实世界α测试中成功实时区分MES 0与MES 1。
要点
- AI模型对溃疡性结肠炎内镜视频分类准确率为82%,与专家评分无显著差异。
- 作为支持系统,AI使非IBD专家评分表现提升12%。
- AI与主治医师意见不一致的比例为20%–39%。
核心结论
- 该AI模型在提升溃疡性结肠炎严重程度分类准确性及非IBD专家熟练度方面显示出显著潜力。
- 模型专为临床使用设计,并在真实世界测试中证明可行。
研究设计与样本
- 使用645例患者的2561张图像和53段视频的Mayo内镜评分(MES)训练卷积神经网络。
- 模型通过开放集识别区分可评分与不可评分的内镜片段。
- 验证使用44例溃疡性结肠炎患者的140段视频,由6名IBD专家和16名非专家评分,以专家评分为金标准。
- 最后在真实世界患者上进行α测试作为实时内镜支持。
主要发现
- 模型准确率为82%,与专家之间无显著差异。
- 作为支持系统使用时,非IBD专家的表现提升12%。
- 模型与主治医师意见不一致的比例为20%–39%。
- α测试中模型成功整合入临床实践,准确区分MES 0与MES 1,与内镜医师评估一致。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Endoscopic classification of ulcerative colitis (UC) shows high interobserver variation. Previous research demonstrated that artificial intelligence (AI) can match the accuracy of central reading in scoring still images. We now extend this assessment to longer colon segments and integrate AI into clinical workflows, evaluating its use for real-time, video-based classification of disease severity, and as a support system for physicians. METHODS: We trained a convolutional neural network with the Mayo Endoscopic Subscores (MESs) of 2,561 images and 53 videos from 645 patients. The model differentiated scorable from unscorable endoscopy sections through open-set recognition. Validation involved 140 video clips from 44 patients with UC. Six inflammatory bowel disease (IBD) experts and 16 nonexperts rated these videos, with expert scores as the gold standard. We assessed the model's performance and the value as a supporting system. Last, the model underwent an alpha test on a real-world patient as a real-time endoscopic support. RESULTS: The model achieved an accuracy of 82%, with no significant differences between the experts and the AI. When used as a supporting system, it improved non-IBD experts' performance by 12% and disagreed with the primary physician in 20%-39% of cases. During the alpha test, it was successfully integrated into clinical practice, accurately distinguishing between MES 0 and MES 1, consistent with endoscopists' assessments. DISCUSSION: Our innovative AI model shows significant potential for enhancing the accuracy of UC severity classification and improving the proficiency of non-IBD experts. It is designed for clinical use and has proven feasible in real-world testing.
引用
- Lo B, Møller B, Igel C, et al. Improving the Real-Time Classification of Disease Severity in Ulcerative Colitis: Artificial Intelligence as the Trigger for a Second Opinion. Am J Gastroenterol. 2025. PMID: 40019166. doi:10.14309/ajg.0000000000003382
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。